Skip to content
★ Sign in to follow
Rhythm Biosciences Limited logo

Rhythm Biosciences Limited Stock: price and insider trades · Australia

AU·Mcap A$23.7MHealth Care

Rhythm Biosciences Limited: what insiders have been doing

Rhythm Biosciences Limited, classified in the Health Care sector, is a listed company based in Australia. Its insiders report their share dealings to ASX. Over the twelve months to 23 October 2026, 3 filings were filed, from 3 insiders.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

With 3 filings in twelve months, the company is quieter than the median of 4 filings across the 1,594 companies we follow on the same exchange.

There has been no open-market purchase by an insider of Rhythm Biosciences Limited for at least a year.

In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.

Key facts

Headquarters: Australia

Source: Wikidata (CC0).

Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

as of FY 2026

FY ended June 2026 · cache

A$0.07
Analyst consensus
1 analysts
·
A$0.54Target A$0.54(+699%)A$0.54
Income statement
RevenueA$85.3k
Gross profit-A$274.6k-322% margin
EBITDA-A$5.7M-6639% margin
Net income-A$5.9M-6948.8% margin
Valuation
P/Book6.7x
Beta0.57
Balance sheet & cash
Market capA$23.7M
Total debtA$248k
Free Cash Flow-A$5.3M
Debt / Equity7%
Profitability & ownership
ROE-276.0%
ROA-96.2%
% insiders24.0%
% institutions9.8%
Last declaration on 30 September 2026
Declarations3 total

3 of 3 declarations

About Rhythm Biosciences Limited

RHY is a company listed on the XASX market. It operates in the financial sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations